Unilateral versus bilateral hilar stents for the treatment of cholangiocarcinoma: a multicenter international study
Staub J, Siddiqui A, Murphy M, Lam R, Parikh M, Pleskow D, Papachristou G, Sharaiha R, Iqbal U, Loren D, Kowalski T, Noor A, Mumtaz T, Yasuda I, Thomas S, Hsaeeb A, Herrick J, Greene T, Adler DG. Unilateral versus bilateral hilar stents for the treatment of cholangiocarcinoma: a multicenter international study. Annals Of Gastroenterology 2020, 33: 202-209. PMID: 32127742, PMCID: PMC7049245, DOI: 10.20524/aog.2020.0451.Peer-Reviewed Original ResearchSelf-expanding metal stentsClinical success rateBilateral stentsAdverse eventsUnilateral stentsBismuth classificationTechnical successStent occlusionClinical successGreater riskInternational retrospective studyMore adverse eventsTreatment of cholangiocarcinomaMulticenter international studySuccess rateBilateral stent placementInoperable cholangiocarcinomaPalliative therapyBilateral drainageBiliary obstructionClinical outcomesRetrospective studyStent groupEndoscopic placementUnresectable cholangiocarcinoma